FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

JBCHEPHARM Share Price Target

J B Chemicals & Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
... Read more
JBCHEPHARM Long Term Analysts Rating
5/5 (1 Ratings)
JBCHEPHARM Share Price *
497 +13 (2.69%)
* (quote may be delayed)

1 JBCHEPHARM share price target reports by brokerages below. See what is analyst's view on JBCHEPHARM share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.


You can also find JBCHEPHARM share price target tomorrow or next week from JBCHEPHARM discussion forum.

JBCHEPHARM Share Price Forecast - Consensus
No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
455.00
Consensus Potential
-6.37%

JBCHEPHARM Share Price Target - Broker Reports - 2019

AnandRathi
24-May-19
Price @ Call: 372.99
Target: 455
BUY
We expect return ratios and operating margins to improve further, coupled with positive cash-flows and its debt-free status, rendering valuations attractive as the stock currently trades at a discount to its peers. We maintain a Buy, with a higher target of Rs 455 (earlier Rs 416) based on14x FY21e earnings.
... Read more

JBCHEPHARM Share Price Target - Broker Reports - 2018

AnandRathi
26-Dec-18
Price @ Call: 294.98
Target: 416
BUY

JBCHEPHARM Share Price Target - Broker Reports - 2017

CD Equisearch
3-Mar-17
Price @ Call: 329
Target: 386
ACCUMULATE

JBCHEPHARM Share Price Target - Broker Reports - 2016

CD Equisearch
14-Dec-16
Price @ Call: 343
Target: 456
BUY

  • JBCHEPHARM - Share Price Target Potential

    keyboard_arrow_down
    BrokerageTargetPotential
    AnandRathi455-6.37%
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.